Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can a 15-Minute daily device zap and chill your way to better skin?

NCT ID NCT07510581

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only This study
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing whether using a device that delivers microcurrent and cold therapy for 15 minutes each day can improve skin firmness, reduce wrinkles, and even out skin tone. About 100 adults aged 25 to 65 with mild to moderate skin concerns will use the device at home for 8 weeks. Researchers will measure changes through expert grading, special imaging, and participant feedback.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 100 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Apr 2026

An estimate. Start dates often move.

Expected to finish

Jun 2026

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

25 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Subject is female or male (approximately 85% female and 15% male) * Subject is between the ages of 25-65 (no more than 25% 55-65 per group) * Individuals with fine lines/wrinkles, lack of firmness, dullness, and uneven skin tone with a grade of at least 3 on a 10-point scale. * Individuals with sensitive skin. * Individuals who are able to cooperate with the Principal Investigator and study personnel throughout the duration of the study and are willing to comply with all study procedures, methods, evaluations, and study product use. * Individuals who are able to read and sign and informed consent. * Individuals who are able to receive emails on their cellular phones and are capable of completing electronic Informed Consents and/or Questionnaires on their device. * Individuals willing to be photographed and sign a model release. Exclusion Criteria: * Individuals who have had Botox in the last 3 months prior to Baseline. * Individuals who have had Filler (Including Lip Filler) in the last 6 months prior to Baseline. * Individuals with a history of atopic eczema, psoriasis, or onychomycosis. * Individuals who have used a topical or system medication within 14 days prior to Baseline. * Individuals who are on anti-acne drugs, topical and/or oral retinoids. * Individuals currently on GLP1 medications or other weight loss regimens. * Individuals who have used a beauty device of any kind in a clinical testing facility in the past 5 months prior to Baseline. * Individuals who have used self-tanners and/or tanning beds within 14 days prior to Baseline. * Individuals currently participating in other clinical studies that are testing a face product and/or device. * Individuals with uncontrolled medical condition(s), including dermatological problems, which could put them at risk in the opinion of the Principal Investigator or compromise the study outcome and/or chronic or serious diseases and conditions which would prevent participation in this clinical study such as cancer, AIDS, insulin-dependent diabetes, renal impairment, mental illness, and/or drug/alcohol addiction. * Individuals with a history of melanoma, or a treated skin cancer within the last 5 years. * Individuals who are pregnant, lactating, or planning to become pregnant. -Individuals who become pregnant during the study must inform the Principal Investigator immediately. * Individuals who are unreliable or unlikely to be available for the duration of the study. * Individuals with a history of allergic reactions, skin sensitization and/or known allergies to cosmetic and personal care products/ingredients. * Individuals who are immunocompromised. * Individuals who are employees of VCS, other testing firms/laboratories, consumer products, and/or raw goods manufacturers/suppliers. * Individuals who are unable to communicate or cooperate with the Principal Investigator/study personnel due to language problems, poor mental development, or impaired cerebral function. * Individuals who started hormones within the last three months preceding the commencement of the study. * Individuals who are using oral contraception for less than three months before study commencement or who have changed their contraceptive method within the three months before the Baseline visit or planning to modify their contraception treatment within the duration of the study. * Individuals who have regular salon and/or dermatological procedures that can interfere with study results (Microdermabrasion, Fillers, Facial Peels, etc.) and are not willing to stop throughout the study. * Individuals with facial tattoos and facial piercings (that can't be removed). * Individuals with tattooed/permanent make up (i.e., eyeliner, eyebrows, lip liner, etc.), eyebrow microblading, and/or eyelash extensions. * Individuals who plan to change their hairstyle throughout the course of the study or who wear hair coverings regularly (i.e., wigs, coloring, extensions, etc.).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Skin health are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Validated Claim Support

    Teaneck, New Jersey, 07666, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.